Denali Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-162,703
| Closed | -$10.3M | – | 330 |
|
|
2019
Q3 | $10.3M | Sell |
162,703
-300
| -0.2% | -$19K | 1.44% | 22 |
|
|
2019
Q2 | $11M | Buy |
163,003
+20,700
| +15% | +$1.4M | 1.65% | 22 |
|
|
2019
Q1 | $9.25M | Sell |
142,303
-18,300
| -11% | -$1.19M | 1.48% | 28 |
|
|
2018
Q4 | $10M | Hold |
160,603
| – | – | 1.68% | 27 |
|
|
2018
Q3 | $12.4M | Buy |
160,603
+5,200
| +3% | +$401K | 1.82% | 25 |
|
|
2018
Q2 | $11M | Buy |
155,403
+14,300
| +10% | +$1.01M | 1.65% | 28 |
|
|
2018
Q1 | $10.6M | Sell |
141,103
-200
| -0.1% | -$15.1K | 1.71% | 21 |
|
|
2017
Q4 | $10.1M | Buy |
141,303
+1,726
| +1% | +$124K | 1.57% | 27 |
|
|
2017
Q3 | $11.3M | Sell |
139,577
-9,300
| -6% | -$754K | 1.87% | 19 |
|
|
2017
Q2 | $10.5M | Sell |
148,877
-2,000
| -1% | -$142K | 1.72% | 22 |
|
|
2017
Q1 | $10.2M | Buy |
150,877
+25,664
| +20% | +$1.74M | 1.51% | 26 |
|
|
2016
Q4 | $8.97M | Sell |
125,213
-52,860
| -30% | -$3.79M | 1.56% | 20 |
|
|
2016
Q3 | $14.1M | Buy |
178,073
+42,973
| +32% | +$3.4M | 2.14% | 14 |
|
|
2016
Q2 | $11.3M | Buy |
135,100
+114,200
| +546% | +$9.53M | 1.94% | 15 |
|
|
2016
Q1 | $1.92M | Buy |
+20,900
| New | +$1.92M | 0.42% | 70 |
|